Keefe, Bruyette & Woods Reaffirms Moderate Buy Rating for Globe Life (NYSE:GL)

Globe Life (NYSE:GL)‘s stock had its “moderate buy” rating reissued by research analysts at Keefe, Bruyette & Woods in a research note issued on Thursday, Marketbeat.com reports. They currently have a $168.00 target price on the stock. Keefe, Bruyette & Woods’ price objective points to a potential upside of 24.20% from the company’s current price.

GL has been the subject of a number of other reports. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, February 13th. Wells Fargo & Company upped their target price on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a research note on Wednesday, February 25th. Evercore set a $157.00 price target on shares of Globe Life in a research note on Wednesday, February 18th. TD Cowen reissued a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Finally, Truist Financial increased their price objective on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $172.00.

Globe Life Stock Performance

Shares of NYSE GL opened at $135.26 on Thursday. The business has a fifty day simple moving average of $141.45 and a 200 day simple moving average of $138.85. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $10.61 billion, a price-to-earnings ratio of 9.61 and a beta of 0.46. Globe Life has a one year low of $109.38 and a one year high of $152.71.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the firm earned $3.14 EPS. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Sell-side analysts expect that Globe Life will post 13.87 EPS for the current year.

Insider Buying and Selling

In other news, Director Mark A. Blinn sold 1,750 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the transaction, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael Clay Majors sold 30,000 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the sale, the executive vice president directly owned 47,066 shares in the company, valued at $6,913,524.74. This trade represents a 38.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 82,807 shares of company stock valued at $12,041,286. Insiders own 1.51% of the company’s stock.

Institutional Investors Weigh In On Globe Life

Institutional investors and hedge funds have recently made changes to their positions in the company. Allianz Asset Management GmbH grew its position in shares of Globe Life by 55.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock worth $11,761,000 after buying an additional 29,256 shares during the period. Synergy Asset Management LLC boosted its stake in Globe Life by 1,022.7% in the third quarter. Synergy Asset Management LLC now owns 100,603 shares of the company’s stock valued at $14,240,000 after acquiring an additional 91,642 shares during the last quarter. Retirement Systems of Alabama bought a new position in Globe Life in the third quarter valued at approximately $2,470,000. SteelPeak Wealth LLC acquired a new stake in Globe Life during the 3rd quarter worth $2,985,000. Finally, Pzena Investment Management LLC raised its position in shares of Globe Life by 5.6% during the 3rd quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock valued at $142,756,000 after acquiring an additional 52,523 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.